TNS4 and gastric cancer: Although contrasting observations exist, for example, an IHC assessment of 89 GC patients identified TNS4 positivity (55.06%) primarily in moderately differentiated intestinal-type tumors without mucinous components (a subtype associated with better prognosis), it should be noticed that no survival correlation was observed [136].